Zeus Capital30 Jun 2025 15:03
LONDON and PHILADELPHIA - June 30, 2025 - Avacta Therapeutics (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces
the appointment of Zeus Capital as a joint broker to the Company with immediate effect.